Clinical Trial Update: A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain. [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 study to evaluate the long-term safety and tolerability of S,S-Reboxetine in patients with post-shingles pain, but the trial was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• S,S-Reboxetine (reboxetine)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 2 | Status: TERMINATED